Top reasons driving health professionals out of the NHS: Work stress, high workload, and understaffing

Work stress, high workload, and understaffing are the primary factors driving health professionals out of the NHS, suggest the results of a survey published in the open access journal BMJ Open.

Startup BioAge raises $170 million Series D for Zepbound combination therapy

A California biotech developing a combination therapy with the obesity drug Zepbound has raised a $170 million Series D round. The company, BioAge, raised money

February 13, 2024

Mainz Biomed Expands into Romania Through Partnership with Bioclinica – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 20.06.2023 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

June 21, 2023

Spice herbs for diabetes treatment: A focus on Trachyspermum ammi and Pimpinella anisum

Announcing a new article publication for BIO Integration journal. Diabetes mellitus (DM) arises from a cascade of factors, primarily stemming from defective insulin secretion by

September 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.